Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience

Published:2020-05-06 Issue:6 Volume:18 Page:1320-1323
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Testa Sophie¹^ORCID,Prandoni Paolo²,Paoletti Oriana¹,Morandini Rossella¹,Tala Maurizio¹,Dellanoce Claudia¹,Giorgi‐Pierfranceschi Matteo³,Betti Monia⁴,Danzi Gian Battista⁵,Pan Angelo⁶,Palareti Gualtiero²

Affiliation:

1. Haemostasis and Thrombosis Center Cremona Hospital Cremona Italy

2. Arianna Anticoagulazione Foundation Bologna Italy

3. Division of Internal Medicine Cremona Hospital Cremona Italy

4. Division of Pneumology Cremona Hospital Cremona Italy

5. Division of Cardiology Cremona Hospital Cremona Italy

6. Division of Infectious Disease Cremona Hospital Cremona Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14871

Reference22 articles.

1. The Novel Coronavirus Originating in Wuhan, China

2. World Health Organization (WHO).Coronavirus disease 2019 (COVID‐19) Situation Report – 51.2020.

3. Oral Anticoagulant Therapy

4. Evidence-Based Management of Anticoagulant Therapy

5. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Oral Anticoagulant Users with Non-users Admission Laboratory Parameters, Length of Hospital Stay and Outcomes in COVID-19 Infection;Global Emergency and Critical Care;2024-08-08

2. Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers;Clinical Pharmacokinetics;2024-02-23

3. Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection;American Journal of Cardiovascular Drugs;2023-12-24

4. Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19;CHEST;2023-12

5. Involvement of multiple cytochrome P450 isoenzymes in drug interactions between ritonavir and direct oral anticoagulants;Drug Metabolism and Pharmacokinetics;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3